Penn AI study of 400,000 Reddit posts on Ozempic and other GLP-1s flags overlooked symptoms

A University of Pennsylvania study used artificial intelligence to analyze roughly 400,000 Reddit posts about GLP-1 medications and found symptom patterns that get little space in clinical trial adverse event tables, according to an account of the work reported Sept. 14, 2026 ^[1]. The posts covered medications including Ozempic and Wegovy (semaglutide) and Mounjaro and Zepbound (tirzepatide) ^[1].

The analysis drew on more than five years of posts from nearly 70,000 users ^[1]. Researchers used large language models to map informal, everyday symptom descriptions onto standardized medical terms, which let them spot recurring patterns across thousands of conversations that would be hard to code by hand at that scale ^[1].

Menstrual changes were mentioned by about 4% of users who reported side effects, and those reports included heavy bleeding and altered cycles ^[1]. Temperature-related complaints — chills, feeling cold, hot flashes and fever-like sensations — also appeared frequently, while fatigue was the second most common complaint overall ^[1]. Gastrointestinal issues remained the most frequently reported symptom in the Reddit posts ^[1].

The findings are described as research leads, not proof that any of these drugs caused the symptoms ^[1]. Reddit data cannot establish incidence or causation, and the posts come from a group that tends to be younger, more male and concentrated in the United States ^[1]. The posts are self-reported and generally unverified ^[1].

Why a hypothalamus link is drawing attention

GLP-1 drugs can affect pathways involving the hypothalamus, a brain region that helps regulate hunger, hormones, reproduction and body temperature ^[1]. That overlap is one reason researchers say menstrual and temperature-related reports deserve closer examination in controlled studies ^[1]. It does not establish that Ozempic, Wegovy, Mounjaro or Zepbound cause those symptoms ^[1].

Why it matters for patients

Clinical trials are built to identify common and serious adverse events, but they may not capture everything patients notice between visits ^[1]. Symptoms a person considers minor, awkward to raise or unrelated to their medication may never come up in a short appointment — and what is not discussed is not recorded ^[1]. The Reddit analysis suggests some of those conversations are happening online instead ^[1].

A pattern in social media posts is still not a safety finding. It cannot tell anyone whether a symptom they are experiencing comes from their medication, from an underlying condition, or from something else ^[1]. The study's own framing is that the results point to questions for formal research rather than answers ^[1].

For people weighing or taking these drugs, the practical takeaway is narrow: the list of symptoms under investigation is wider than what shows up in trial tables, but how often any of it happens has not been established ^[1].

What is not yet known

No rates of menstrual changes, temperature symptoms or fatigue across all GLP-1 users have been reported from this work ^[1]. Whether the reported symptoms were tied to the medications, to underlying conditions, or to other factors has not been determined ^[1]. The researchers call for controlled studies and broader safety monitoring, and no timeline for such studies has been disclosed ^[1]. Expanding the approach across other languages and populations has been suggested as a next step, but no plan or schedule has been reported ^[1].

AI-driven social listening can process far more patient commentary than manual review, and the researchers present it as a way to complement existing safety monitoring by flagging concerns for study rather than replacing it ^[1].